ACRV vs MRNA (Acrivon Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Sep, 15 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 5:51 PM ET. All metrics below represent finalized session performance.
MRNA leads by +8.39% Alpha Spread Today
ACRV is trading at -7.10% while MRNA is at +1.29% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | ACRV | MRNA | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -7.10% | +1.29% | MRNA +8.39% |
| Net Dollar Move | $-0.13 | +$1.85 | MRNA higher move |
| Open Price | $1.85 | $145.41 | Gap: 1.09% vs 1.14% |
| Day High | $1.90 | $148.93 | Session peaks |
| Day Low | $1.70 | $142.30 | Session troughs |
| Intraday Spread | $0.20 | $6.63 | High/Low spread |
| Share Volume | 764.3K | 8.80M | MRNA more active |
| Est. Dollar Volume | $1.30M | $1.28B | MRNA higher liquidity |
Explore ACRV vs MRNA Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.